Charles E. Inturrisi

Also affiliated with NRG Oncology

MedicineNeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Cav1.3 L-type Ca2+ channel-activated CaMKII/ERK2 pathway in the ventral tegmental area is required for cocaine conditioned place preference”.

Cav1.3 L-type Ca2+ channel-activated CaMKII/ERK2 pathway in the ventral tegmental area is required for cocaine conditioned place preference

Neuropharmacology(2022)10.1016/j.neuropharm.2022.109368

N/A

0DataRank · unranked

5 citations

Hao Jin, Richard C. Rice, Charles E. Inturrisi, Anjali M. Rajadhyaksha, Arlene Martínez-Rivera

Should We Use COMM (Current Opioid Misuse Measure) to Screen for Opioid Abuse in Patients With Cancer Pain?

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.7054

N/A

0DataRank · unranked

8 citations

Tito R. Mendoza, Susan D. Horn, Jelyn C. Eustaquio, Charles S. Cleeland, Charles E. Inturrisi +1 more